Donald R. Jasinski
#155,256
Most Influential Person Now
Donald R. Jasinski's AcademicInfluence.com Rankings
Donald R. Jasinskimedical Degrees
Medical
#3034
World Rank
#3485
Historical Rank
Pharmacology
#354
World Rank
#405
Historical Rank
Download Badge
Medical
Why Is Donald R. Jasinski Influential?
(Suggest an Edit or Addition)Donald R. Jasinski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. (1978) (768)
- Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. (1973) (353)
- Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. (1985) (294)
- The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). (1967) (292)
- Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. (2005) (290)
- A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts (1988) (277)
- Methadone--a reevaluation. (1973) (257)
- Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving (2006) (252)
- Assessment of the Abuse Potentiality of Morphinelike Drugs (Methods Used in Man) (1977) (252)
- Physiological parameters of morphine dependence in man--tolerance, early abstinence, protracted abstinence. (1969) (250)
- Abuse potential and pharmacological comparison of tramadol and morphine. (1991) (233)
- Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. (1988) (226)
- An evaluation of the abuse potential of modafinil using methylphenidate as a reference (2000) (222)
- Clonidine in morphine withdrawal. Differential effects on signs and symptoms. (1985) (164)
- Cigarette smokers self-administer intravenous nicotine (1983) (155)
- Intravenous methylphenidate abuse. Prototype for prescription drug abuse. (1991) (153)
- Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations (2007) (140)
- Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: Lessons from tramadol (2006) (137)
- Effects of short‐ and long‐term administration of pentazocine in man (1970) (128)
- Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone (1968) (127)
- Evaluation of the Abuse Liability of Modafinil and Other Drugs for Excessive Daytime Sleepiness Associated with Narcolepsy (2000) (126)
- Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. (2001) (125)
- Effects of (−)Δ9-trans-tetrahydrocannabinol in man (2004) (124)
- Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse (2009) (123)
- Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. (2009) (122)
- Evaluation of nalbuphine for abuse potential (1972) (110)
- Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. (1986) (109)
- ONE-, THREE-, AND SIX-MONTH OUTCOMES AFTER BRIEF INPATIENT OPIOID DETOXIFICATION (2001) (103)
- Sublingual versus subcutaneous buprenorphine in opiate abusers (1989) (101)
- Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers (2009) (89)
- Abuse liability assessment in human subjects (1984) (88)
- Ritanserin in the treatment of alcohol dependence – a multi-center clinical trial (1996) (87)
- Abuse liability assessment of atomoxetine in a drug-abusing population. (2008) (85)
- Abuse liability studies of opioid agonist-antagonists in humans. (1991) (81)
- A comparison of fenfluramine and amphetamine in man (1975) (79)
- Investigation of the abuse liability of buspirone in alcohol-dependent patients. (1986) (79)
- Human abuse liability assessment by measurement of subjective and physiological effects. (1989) (78)
- Abrupt withdrawal from therapeutically administered diazepam. Report of a case. (1978) (76)
- Prevalence of hepatitis C in a chemically dependent population. (1993) (70)
- Methadone‐naloxone mixtures for use in methadone maintenance programs; I. An evaluation in man of their pharmacological feasibility; II. Demonstration of acute physical dependence (1974) (70)
- Morphine effects on human REM state, waking state and NREM sleep (2004) (70)
- Studies of the dependence‐producing properties of GPA‐1657, profadol, and propiram in man (1971) (66)
- Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving (2007) (61)
- Highly active antiretroviral therapy outcomes in a primary care clinic (2003) (57)
- The respiratory effects of morphine during a cycle of dependence. (1968) (56)
- Effects of (--)delta-9-trans-tetrahydrocannabinol in man. (1967) (55)
- Effects of diethylpropion and d‐amphetamine after subcutaneous and oral administration (1974) (55)
- Comparison of intravenously administered methadone, morphine and heroin. (1986) (53)
- Progress report of the NIDA Addiction Research Center. (1982) (51)
- Human pharmacology of narcotic antagonists. (1979) (49)
- Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations (2012) (48)
- The psychopharmacologic and prolactin response after large doses of naloxone in man (1988) (45)
- Liver disease in narcotic addicts II. The role of the needle (1968) (45)
- Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man. (1969) (43)
- Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. (2005) (42)
- A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. (2013) (39)
- Liver disease in narcotic addicts I. The role of the drug (1968) (38)
- Lithium: effects on subjective functioning and morphine-induced euphoria. (1977) (38)
- Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. (1986) (37)
- Assessment of the Abuse Potential of Narcotic Analgesics in Animals (1977) (37)
- The Use of the Polaroid CU Camera in Pupillography (1967) (37)
- History of abuse liability testing in humans. (1991) (37)
- Psychoactivity and abuse potential of sumatriptan (1992) (36)
- Therapeutic usefulness of propoxyphene napsylate in narcotic addiction. (1977) (33)
- Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic. (2012) (32)
- Buprenorphine Reduces Cerebral Glucose Metabolism in Polydrug Abusers (1994) (31)
- Learning Disabilities in Alcohol-Dependent Adults (1990) (30)
- Quantified human sleep after pentobarbital (1972) (29)
- Abuse liability of testosterone (1997) (29)
- A comparison of LSD-25 with (−)-Δ9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC (2004) (28)
- Etorphine in man. I. Subjective effects and suppression of morphine abstinence (1975) (28)
- Clinical Procedures for the Assessment of Abuse Potential (1987) (27)
- Differential effects of μ and κ opioid analgesics on cerebral glucose utilization in the rat (1987) (27)
- Evaluation of a new photographic method for assessing pupil diameters (1967) (26)
- A Comparison of Clonidine and Buprenorphine in the Outpatient Treatment of Opiate Withdrawal (2001) (25)
- Tolerance and dependence to opiates (1997) (25)
- Diuretic action of the narcotic antagonist oxilorphan (1974) (25)
- Electroencephalographic and behavioral correlates of buprenorphine administration (1984) (24)
- Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. (2007) (24)
- OPIATE WITHDRAWAL SYNDROME: ACUTE AND PROTRACTED ASPECTS (1981) (23)
- Development and Preliminary Experience with an Ease of Extractability Rating System for Prescription Opioids (2006) (23)
- The Assessment of the Abuse Potentiality of Sedative/Hypnotics (Depressants) (Methods Used in Animals and Man) (1977) (22)
- Rapid physiologic effects of nicotine in humans and selective blockade of behavioral effects by mecamylamine. (1983) (22)
- Dosing Adjustments in Postpartum Patients Maintained on Buprenorphine or Methadone (2008) (21)
- Assessment of dezocine for morphine‐like subjective effects and miosis (1985) (21)
- Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study. (2006) (21)
- Progress report of the NIDA Addiction Research Center, Baltimore, Maryland, 1982. (1983) (20)
- A Buprenorphine Stabilization and Rapid‐Taper Protocol for the Detoxification of Opioid‐Dependent Patients (1994) (20)
- Evaluation of tilidine for morphine-like subjective effects and euphoria. (1986) (19)
- REVIEW OF THE EFFECTS IN MAN OF MARIJUANA AND TETRAHYDROCANNABINOLS ON SUBJECTIVE STATE AND PHYSIOLOGIC FUNCTIONING (1971) (19)
- Assessment of the Dependence Liability of Opiates and Sedative-Hypnotics (1973) (18)
- Abuse potential of morphine/dextromethorphan combinations. (2000) (17)
- An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs. (1987) (15)
- Abuse potential of oral tramadol (1993) (15)
- Human pharmacology of nicotine. (1983) (14)
- A comparative assay of nefopam, morphine and d-amphetamine (2004) (13)
- Abstinence incentive effects in a short-term outpatient detoxification program. (2004) (12)
- Abuse Liability Of Intravenous Lisdexamfetamine Dimesylate [LDX; NRP104] (2006) (11)
- Psychopharmacology and abuse potential of transnasal butorphanol. (1994) (11)
- Assessment of the dependence‐producing properties of dihydrocodeinone and codoxime (1967) (11)
- Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users. (1997) (10)
- Cerebral glucose utilization in human heroin addicts: Case reports from a positron emission tomographic study (1989) (10)
- Azidomorphine: Subjective effects and suppression of morphine abstinence (1976) (10)
- Stimulus control and drug dependence. (1981) (9)
- Five-Year Outcomes of a Cohort of HIV-Infected Injection Drug Users in a Primary Care Practice (2006) (9)
- Naloxone fails to alter local cerebral glucose utilization in the rat (1988) (9)
- Effects of tramadol in humans: assessment of its abuse potential. (1989) (8)
- Human pharmacology and abuse potential of meptazinol (1987) (8)
- Progress report from the NIDA Addiction Research Center. (1979) (8)
- Progress report from the NIDA Addiction Research Center, Baltimore, Maryland. (1984) (7)
- l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog. (1997) (7)
- A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties. (1987) (7)
- The clinical pharmacology of pentazocine and tripelennamine (T's and Blues). (1986) (7)
- Conceptual basis of replacement therapies for chemical dependence. (1988) (7)
- Nicotine: Abuse Liability, Dependence Potential and Pharmacologic Treatment of Dependence (1987) (6)
- Human studies of the behavioral pharmacological determinants of nicotine dependence. (1986) (6)
- Effects of opioid analgesics on local cerebral glucose utilization. (1986) (6)
- A resident clerkship that combines inpatient and outpatient training in substance abuse and HIV care. (2005) (5)
- Interdisciplinary studies on phencyclidine at the Addiction Research Center, Lexington, Kentucky [proceedings]. (1980) (4)
- Erratum: Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving (Neuropsychopharmacology (2007) 31, (2714-2725) DOI: 10.1038/sj.npp.1301194) (2007) (4)
- Pharmacologic basis for nicotine replacement. (1988) (4)
- Comparison of intravenously administered methadone (ME), morphone (MO), heroin (H) and placebo (P) (1973) (4)
- Evaluation of the 5HT3 antagonist ondansetron (O) for cocaine (C)-like activity and abuse potential. (1990) (3)
- Physiologic parameters of morphine dependence in man--tolerance, early abstinence, protracted abstinence. (1970) (3)
- Single‐dose pharmacodynamics of diazepam and pentobarbital in substance abusers (1993) (3)
- Relative abuse liability and pharmacodynamics of transnasal and intramuscular butorphanol. (1990) (3)
- Abuse potential of diazepam (Valium) (1982) (2)
- Differential effects of mu and kappa opioid analgesics on cerebral glucose utilization in the rat. (1987) (2)
- Skin conductance responses to hypercapnia in man during a cycle of addiction to morphine (2004) (2)
- Comparison of drug treatment histories of single and multiple drug abusers in detox. (2001) (1)
- Clinical pharmacology of mixed agonist-antagonist drugs [proceedings]. (1981) (1)
- Lithium (Li): Lack of effect on morphine (MS) euphoria (1973) (1)
- Evaluation of the abuse potential of picenadol. (1989) (1)
- Butorphanol: A kappa agonist revisited (1994) (1)
- 5-HT3 receptor antagonism and psychoactivity (1996) (1)
- Differential Effects on Signs and Symptoms (2015) (1)
- Abuse potential of zomepirac (1983) (1)
- Patterns of drug abuse in detoxification patients (1993) (0)
- GABAA RECEPTOR PLASTICITY IN THE HIPPOCAMPUS OF SOCIALLY ISOLATED C57BL/6J MICE EXPOSED TO VOLUNTARY ETHANOL CONSUMPTION (2010) (0)
- Diuretic activity of a new narcotic antagonist in man (Bristol compound 2605) (1973) (0)
- Proceedings Supplement NMDA-Receptor Antagonists: Evolving Role in Analgesia (2000) (0)
- Human pharmacology and abuse liability of BW942C (1999) (0)
- Chemotherapy of Addiction — A Pharmacological Perspective (1981) (0)
- P.6.c.010 Abuse liability of intravenous lisdexamfetamine dimesylate (2008) (0)
- Clinical syndromes associated with narcotic addiction and withdrawal (1986) (0)
- Abuse Potential of Mild Analgesics (1973) (0)
- Measurement of subjective effects (1974) (0)
- INTRODUCTORY REMARKS (1978) (0)
- Progress report from the NIDA Addiction Research Center Baltimore, Maryland (1984). (1984) (0)
- Comparison of intravenous cocaine on blood flow in the peripheral and pulmonary circulations (1993) (0)
- Response from the authors, 15, 401-402 (2006) (0)
- Short communication Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes (2001) (0)
- Recent developments in chemotherapy of narcotic addiction. Part VI. LAAM and narcotic antagonists: introductory remarks. (1978) (0)
- STRIATAL DOPAMINE RELEASE IS COMPROMISED IN ALCOHOL-DEPENDENT SUBJECTS (2010) (0)
- NMDA-Receptor Antagonists: Evolving Role in Analgesia Abuse Potential of Morphine/ Dextromethorphan Combinations (2000) (0)
- Response from the authors [2] (2006) (0)
- Human Pharmacology and Abuse Potential of an Enkephalin Like Pentapeptide: BW942C (1999) (0)
- Buprenorphine: Evaluation of oral and sublingual routes (1982) (0)
- A REVIEW OF THE ABUSE LIABILITY OF ATOMOXETINE, A NONSTIMULANT PHARMACOTHERAPY FOR ADHD (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Donald R. Jasinski?
Donald R. Jasinski is affiliated with the following schools:
